AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

10,436.00p
   
  • Change Today:
      62.00p
  • 52 Week High: 13,276.00
  • 52 Week Low: 9,667.00
  • Currency: UK Pounds
  • Shares Issued: 1,550.64m
  • Volume: 3,093,899
  • Market Cap: £161,825m
  • RiskGrade: 123
  • Beta: 0.02

Key dates

Dividend  
Latest XD Date (2nd Interim) 20-Feb-2025
Latest Pay Date (2nd Interim) 24-Mar-2025
   
Meetings  
AGM 11-Apr-2025
EGM n/a
GMs n/a
   
Announcements  
Trading announcement n/a
IMSs n/a
Drilling Report n/a
   
Results  
Final results 06-Feb-2025
Interim results 29-Jul-2025
Q1 Results 29-Apr-2025
Q2 Results 29-Jul-2025
Q3 Results 06-Nov-2025
Q4 Results 06-Feb-2025
Annual Report 18-Feb-2025
   
Year End 31-Dec-2025

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

AstraZeneca Market Data

Currency UK Pounds
Share Price 10,436.00p
Change Today 62.00p
% Change 0.60 %
52 Week High 13,276.00
52 Week Low 9,667.00
Volume 3,093,899
Shares Issued 1,550.64m
Market Cap £161,825m
Beta 0.02
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
93.35% below the market average93.35% below the market average93.35% below the market average93.35% below the market average93.35% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
24.51% below the market average24.51% below the market average24.51% below the market average24.51% below the market average24.51% below the market average
31.91% above the sector average31.91% above the sector average31.91% above the sector average31.91% above the sector average31.91% above the sector average
Income
60.44% below the market average60.44% below the market average60.44% below the market average60.44% below the market average60.44% below the market average
14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average
Growth
86.57% above the market average86.57% above the market average86.57% above the market average86.57% above the market average86.57% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

What The Brokers Say

Strong Buy 10
Buy 14
Neutral 5
Sell 0
Strong Sell 0
Total 29
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 20-Feb-25 08-Aug-24
Paid 24-Mar-25 09-Sep-24
Amount 210.00¢ 100.00¢

Trades for 23-May-2025

Time Volume / Share Price
15:31 0 @ 10,424.00p
15:31 0 @ 10,424.00p
15:31 0 @ 10,424.00p
15:16 0 @ 10,404.00p
15:07 0 @ 10,396.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page